2019
DOI: 10.12659/msm.915748
|View full text |Cite
|
Sign up to set email alerts
|

Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats

Abstract: BackgroundDiabetic retinopathy is a primary contributor of visual impairment in adult diabetes mellitus patients. Diabetic retinopathy causes breakdown of blood retinal barrier (BRB), and leads to diabetic macular edema. Previous studies have demonstrated angiopoietin-like protein 4 (ANGPTL4) as an effective diabetic retinopathy therapeutic target, however, its role in maintaining the outer BRB in diabetic retinopathy has yet not elucidated.Material/MethodsWe established an in vivo diabetic rat model with the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 37 publications
(41 reference statements)
0
10
0
Order By: Relevance
“…ANGPTL4 is mainly expressed in the liver and plays a key role in inflammation, angiogenesis, and tumors. Recent studies have shown that ANGPTL4 is a therapeutic target for retinopathy of DR patients [ 18 ]. At the same time, this study also found that the levels of VEGF, MCP-1, and ANGPTL4 in the two groups decreased after treatment, and the levels of VEGF, MCP-1, and ANGPTL4 in the observation group were lower than those in the control group, suggesting that intravitreal injection of aflibercept in the treatment of DR with macular edema can improve the cytokine levels in the aqueous humor.…”
Section: Discussionmentioning
confidence: 99%
“…ANGPTL4 is mainly expressed in the liver and plays a key role in inflammation, angiogenesis, and tumors. Recent studies have shown that ANGPTL4 is a therapeutic target for retinopathy of DR patients [ 18 ]. At the same time, this study also found that the levels of VEGF, MCP-1, and ANGPTL4 in the two groups decreased after treatment, and the levels of VEGF, MCP-1, and ANGPTL4 in the observation group were lower than those in the control group, suggesting that intravitreal injection of aflibercept in the treatment of DR with macular edema can improve the cytokine levels in the aqueous humor.…”
Section: Discussionmentioning
confidence: 99%
“…in addition, several signaling pathways, including the Pi3K/aKT, STaT3 and mTor signaling pathways, are associated with HiF-1α/VeGF signaling in dr (31)(32)(33). it has been reported that the Pi3K/aKT/mTor signaling pathway promotes dr via inducing retinal cell viability, apoptosis, migration and angiogenesis.…”
Section: Discussionmentioning
confidence: 98%
“…As an angiogenesis factor, ANGPTL4 promotes the pathological processes of diverse eye diseases by enhancing angiogenesis, vascular permeability, and inflammation [ 23 , 24 ]. Aqueous ANGPTL4 was obviously increased in PDR, inducing retinal neovascularization [ 25 , 26 ].…”
Section: Discussionmentioning
confidence: 99%